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Dissertation Abstract 
 
It is likely that fish are exposed to mixtures of several pharmaceuticals as well as 
other pollutants. This may result in increased adverse effects due to chemical 
interactions. Chemical interactions are challenging to predict and will be aided 
by increased knowledge on key detoxification mechanisms. In human, adverse 
drug-interactions can arise by interactions with the pregnane X receptor (PXR) 
and the target genes cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (Pgp). 
These genes also exist in fish, but their functions are less understod in fish. The 
main focus in this thesis was to elucidate whether PXR regulates CYP3A and Pgp 
in fish and how pharmaceuticals interact with regulation of these genes and the 
functions of the proteins. We found weak induction of CYP3A and Pgp genes by 
two mammalian PXR ligands in rainbow trout hepatocytes. Besides, we found 
weak induction of hepatic PXR, CYP3A and Pgp expressions with PCBs in a 
killifish population that is non-responsive to CYP1A inducers. To further explore 
fish PXR activation, rainbow trout PXR was isolated, sequenced and expressed in 
a reporter assay. The reporter assay resulted in weak or no activation of rainbow 
trout PXR with a suite of prototypical PXR ligands. A CYP3B gene transcript was 
sequenced from the Poeciliopsis lucida hepatocellular carcinoma (PLHC-1) cell 
line. Basal expression of CYP3B was low in PLHC-1 cells and it was not 
responsive to exposure to PXR ligands. We have used both in vitro and in vivo fish 
models and we have analysed gene regulations and protein functions upon 
pharmaceutical exposures, both as single substance exposures and as a mixture 
exposure. Several pharmaceuticals were shown to inhibit the CYP1A catalytic 
functions and to interfere with efflux pumps activities in PLHC-1. Combined 
exposure of ethinylestradiol with the broad spectrum CYP inhibitor ketoconazole 
resulted in increased sensitivity to ethinylestradiol exposure in juvenile rainbow 
trout. This drug interaction was caused by inhibition of CYP1A and CYP3A 
enzyme activities in rainbow trout liver. In conclusion, pharmaceuticals affected 
both functions and regulations of key detoxification proteins in fish. Adverse 
toxicokinetic interactions via CYP1A and CYP3A inhibitions were demonstrated 
in rainbow trout. 
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